Trials / Completed
CompletedNCT05790577
Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of Melasma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Ishtiaq Ahmed · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Comparison of 30% Metformin and 2% Nicotinamide lotion with kligman formula in the treatment of Melasma
Detailed description
A comparative study to evaluate Efficacy and tolerability of new lotion in the treatment of Melasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin and Nicotinamide vs Kligman Formula | Comparison of 30% Metformin and 2% Nicotinamide lotion with kligman formula in the treatment of Melasma |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2023-02-15
- Completion
- 2023-02-15
- First posted
- 2023-03-30
- Last updated
- 2023-05-23
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05790577. Inclusion in this directory is not an endorsement.